[The 2006 American Heart Association selection of the "top ten advances in heart disease and stroke research"].
The American Heart Association (AHA) has once again released its "top ten research advances in heart disease and stroke" for the past year. A place of choice is devoted to stroke as well as to pediatric cardiology and to prevention of heart disease in childhood and adolescence. As is the case every year, reading the selected articles is rich of enlightment and the source of a good many thoughts.
Kulbertus
H
H
ULg, Liège.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000293:Adolescent; D000328:Adult; D000572:American Heart Association; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D050197:Atherosclerosis / Q000145:classification; D000069059:Atorvastatin; D002545:Brain Ischemia / Q000150:complications; D002648:Child; D003327:Coronary Disease / Q000628:therapy; D006331:Heart Diseases / Q000517:prevention & control; D006350:Heart Valve Prosthesis; D006353:Heart-Assist Devices; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D002546:Ischemic Attack, Transient / Q000150:complications; D008875:Middle Aged; D009203:Myocardial Infarction / Q000503:physiopathology; D009204:Myocardial Revascularization; D009765:Obesity / Q000517:prevention & control; D007703:Peptidyl-Dipeptidase A / Q000009:adverse effects; D017064:Process Assessment, Health Care; D011758:Pyrroles / Q000627:therapeutic use; D020521:Stroke / Q000517:prevention & control; D023822:Tissue Engineering; D014481:United States
D000893:Anti-Inflammatory Agents; D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin; D007703:Peptidyl-Dipeptidase A